Ligand · AXA
AXA · (5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide
AXA, (5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide (C22 H21 N5 O5 S, 467.5 g/mol), in the MolNFT structures on GenesisL1: bound in…
- Component
- AXA
- Formula
- C22 H21 N5 O5 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
AXA in 2 structures; the first of them:
- 3DNG · Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor · AXA A1 · binds LEU160, PHE192, LEU193, VAL194, HIS197, GLU198, ALA213, LEU214 and 12 more
- 3DNG · Crystal structure of the complex between mmp-8 and a non-zinc chelating inhibitor · AXA A1 · binds LEU160, PHE192, LEU193, VAL194, HIS197, GLU198, ALA213, LEU214 and 12 more
Residues it binds most
LEU 4, TYR 4, ALA 4, ASN 4, PHE 4, PRO 4, ARG 4, GLU 4, HIS 4, SER 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.